Angiola Rocino

3.9k total citations
87 papers, 2.9k citations indexed

About

Angiola Rocino is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Angiola Rocino has authored 87 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 20 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Angiola Rocino's work include Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (19 papers). Angiola Rocino is often cited by papers focused on Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (19 papers). Angiola Rocino collaborates with scholars based in Italy, Spain and Sweden. Angiola Rocino's co-authors include Elena Santagostino, Pier Mannuccio Mannucci, Massimo Morfini, Maria Elisa Mancuso, Antonio Coppola, A. Gringeri, Annarita Tagliaferri, Giancarlo Castaman, F. A. Scaraggi and R. De Biasi and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Angiola Rocino

83 papers receiving 2.7k citations

Peers

Countries citing papers authored by Angiola Rocino

Since Specialization

Citations

This map shows the geographic impact of Angiola Rocino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angiola Rocino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angiola Rocino more than expected).

Fields of papers citing papers by Angiola Rocino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angiola Rocino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angiola Rocino. The network helps show where Angiola Rocino may publish in the future.

Co-authorship network of co-authors of Angiola Rocino

This figure shows the co-authorship network connecting the top 25 collaborators of Angiola Rocino. A scholar is included among the top collaborators of Angiola Rocino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angiola Rocino. Angiola Rocino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers	SHILAP Revista de lepidopterología	Gianfranco Pasut, Angiola Rocino et al.	0
2	The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey	Haemophilia	Arianna Fornari, Ippazio Cosimo Antonazzo et al.	3
3	Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding.	PubMed	Antonio Coppola, Massimo Franchini et al.	14
4	Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project	Nova Science Publishers (Nova Science Publishers, Inc.)	Chiara Biasoli, Erminia Baldacci et al.	9
5	Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians	Journal of Thrombosis and Thrombolysis	Alessandra Borchiellini, Giancarlo Castaman et al.	2
6	Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors	Haemophilia	Giovanni Di Minno, Antonio Coppola et al.	10
7	Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres	British Journal of Haematology	Matteo Nicola Dario Di Minno, Mariasanta Napolitano et al.	17
8	Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET	Haemophilia	Antonio Coppola, Giancarlo Castaman et al.	19
9	Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry	Haemophilia	Ezio Zanon, Samantha Pasca et al.	2
10	Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry	Journal of Thrombosis and Thrombolysis	Samantha Pasca, Chiara Ambaglio et al.	12
11	Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL)	Value in Health	Sylvia von Mackensen, Silvia Riva et al.	4
12	Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A	Journal of Thrombosis and Haemostasis	Maria Elisa Mancuso, Pier Mannuccio Mannucci et al.	40
13	Cost of Immune Tolerance Induction in Hemophilia A Patients: Results from the ITER Study	Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)	Francesca Fusco, L Scalone et al.	1
14	Recommendations for assessment, monitoring and follow‐up of patients with haemophilia	Haemophilia	Philippe de Moerloose, Kathelijn Fischer et al.	47
15	European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study	Haemophilia	Elena Santagostino, G. Auerswald et al.	7
16	Mortality and causes of death in Italian persons with haemophilia, 1990–2007	Haemophilia	Annarita Tagliaferri, G Rivolta et al.	136
17	Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy	Haemophilia	Veronica Sanna, Federica Zarrilli et al.	9
18	A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors	Thrombosis and Haemostasis	Elena Santagostino, Angiola Rocino et al.	10
19	Current use of by‐passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors	Haemophilia	Jan Astermark, Angiola Rocino et al.	43
20	Successful Immune Tolerance Treatment with Monoclonal or Recombinant Factor VIII Concentrates in High Responding Inhibitor Patients	Vox Sanguinis	Angiola Rocino et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact